Nandrolone vs VIP
FDA Approved vs Extensively Studied
avoid Mechanism-based · 70% Both Nandrolone and VIP carry cardiovascular risk. Combined cardiotoxic load increases risk of cardiac events. Regular cardiac monitoring recommended.
Molecular Data
Nandrolone VIP
Weight 274.40 Da (base) 3,326 Da
Half-life ~6-12 days (decanoate) 1-2 minutes
Chain — 28 amino acids
Type 19-nortestosterone steroid (C18H26O2) Neuropeptide
Key Benefits
Nandrolone
01 Significant increases in lean muscle mass with a favorable anabolic-to-androgenic ratio
02 Enhanced collagen synthesis and joint lubrication, reducing joint pain and improving connective tissue integrity
03 Increased bone mineral density through direct osteoblast stimulation
04 Improved nitrogen retention and protein synthesis for accelerated recovery
05 Stimulation of erythropoietin production, increasing red blood cell mass and oxygen delivery
06 Lower androgenic side effects (hair loss, acne, prostate enlargement) compared to testosterone
07 Clinically demonstrated efficacy in treating anemia of chronic renal failure
08 Potential neuroprotective properties observed in preclinical research
VIP
01 Potent vasodilation and blood pressure reduction
02 Strong anti-inflammatory effects
03 Immunomodulation (Th1-Th2 balance)
04 Neuroprotective effects
05 Bronchodilation
06 Cardioprotective (positive inotropic effects)
07 Insulin secretion enhancement (glucose-dependent)
08 Gut barrier and permeability regulation
Dosing Protocols
Nandrolone
100-200 mg/week (therapeutic) / 1x per week (decanoate) or 2-3x per week (NPP)
TRT Adjunct - Joint Support 50-100 mg/week 1x per week (decanoate)
Therapeutic - Anemia / Wasting 100-200 mg/week 1x per week (decanoate)
Performance Enhancement - Moderate 200-400 mg/week 1x per week (decanoate) or split into 2 injections
NPP Protocol - Shorter Cycle 200-350 mg/week Every other day or 3x per week
VIP
50-100 mcg per dose (up to 200 mcg in research protocols) / 1-2 times daily due to very short 2-minute half-life
General use 50-100 mcg 1-2x daily
Research protocols 100-200 mcg As directed
Side Effects
Nandrolone
Suppression of natural testosterone production (profoundly suppressive, more so than testosterone alone)
Water retention and bloating (less than testosterone at equianabolic doses)
Erectile dysfunction and reduced libido without concurrent testosterone ('deca dick')
Increased appetite and weight gain
Mild acne and oily skin (less pronounced than testosterone)
Elevated hematocrit and hemoglobin (erythrocytosis)
Injection site pain or discomfort
Mild mood changes (some users report increased emotional sensitivity)
VIP
Vasodilation (flushing, warmth)
Hypotension
Increased heart rate
Gastrointestinal effects (diarrhea possible)
Headache
Contraindications
Prostate cancer (active or history of hormone-sensitive prostate cancer)
Breast cancer in males or females
Pregnancy or potential for pregnancy (Category X - causes virilization of female fetus)
Nephrosis or the nephrotic phase of nephritis
Severe hepatic impairment
Hypercalcemia
Known hypersensitivity to nandrolone or any formulation components
Polycythemia (hematocrit above 54% at baseline)
Uncontrolled heart failure or severe cardiovascular disease
Severe hypotension
VIPoma or related tumors
Pregnancy or breastfeeding
Severe cardiac conditions
Research Evidence
Nandrolone VIP
Status FDA Approved Extensively Studied
References 5 studies 4 studies
Latest April 2005 —
FDA Approved Yes No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.